Concepedia

Nguyen C. Pham

NC

6

Publications

885

Citations

6

H-Index

2017

Active since

Affiliations

Ionis Pharmaceuticals (United States)(Current)

University of California San Diego

Nguyen C. Pham is an author at Ionis Pharmaceuticals (United States) specializing in ophthalmology, optogenetics, and glaucoma.

ORCID

Top concepts

Publications per year

2017–2020

6

Publications

6

Cardiovascular and Metabolic Effects of <i>ANGPTL3</i> Antisense Oligonucleotides

Mark J. Graham, Richard Lee, Teresa Brandt et al. · New England Journal of Medicine · 2017 · 567 citations · Full text

The Effects of 2′- <i>O</i> -Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials

Stanley T. Crooke, Brenda F. Baker, Joseph L. Witztum et al. · Nucleic Acid Therapeutics · 2017 · 120 citations · Full text

Homeostatic plasticity in the retina is associated with maintenance of night vision during retinal degenerative disease

Henri Leinonen, Nguyen C. Pham, Taylor Boyd et al. · eLife · 2020 · 74 citations · Full text

, , +18

Antisense Inhibition of Glucagon Receptor by IONIS-GCGRRx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy

Erin Morgan, Nguyen C. Pham, Julia K. Overman et al. · Diabetes Care · 2019 · 49 citations

Antisense Inhibition of Protein Tyrosine Phosphatase 1B With IONIS-PTP-1BRx Improves Insulin Sensitivity and Reduces Weight in Overweight Patients With Type 2 Diabetes

Andrés Digenio, Nguyen C. Pham, Lynnetta M. Watts et al. · Diabetes Care · 2018 · 41 citations

Rows per page

1–5 of 6